The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...

Researchers here described how they were able to safely and ethically enroll adolescents in a landmark trial of a drug that ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

In the general population, frailty is an aging-related risk factor for poor outcomes; individuals experiencing frailty face ...

A low-income housing cooperative for people with HIV and AIDS is fighting to stay open in San Francisco. On Sunday afternoon, ...

SAN FRANCISCO -- At least 400 researchers, physicians, activists, and other concerned citizens gathered here Monday night to ...

Adults living with HIV in Malawi are more than twice as likely to also have dementia compared to those without HIV, according ...

A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...

Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center, collaborates with researchers from the Kenya Medical Research Institute ...